Table 5. Joanna Briggs Institute (JBI) critical appraisal checklist for cohort studies.
Adapted from Per et al., 2013 [23]; Tibussek et al., 2013 [24]; Değerliyurt et al., 2014 [25]; Bursztyn et al., 2014 [26]; Sheldon et al., 2016 [27]; Matthews et al., 2017 [28]; and Mahajnah et al., 2020 [29]. N/A: not applicable.
| Per et al. 2013 [23] | Tibussek et al. 2013 [24] | Değerliyurt et al. 2014 [25] | Bursztyn et al. 2014 [26] | Sheldon et al. 2016 [27] | Matthews et al. 2017 [28] | Mahajnah et al. 2020 [29] | |
| 1. Were the two groups similar and recruited from the same population? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 2. Were the exposures measured similarly to assign people to both exposed and unexposed groups? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 3. Was the exposure measured in a standard, reliable and valid way? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 4. Were confounding factors identified? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 5. Were strategies to deal with confounding factors stated? | Unclear | Yes | Unclear | Unclear | Yes | Unclear | Yes |
| 6. Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)? | No | No | No | No | No | No | No |
| 7. Were the outcomes measured in a reliable and valid way? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 8. Was the follow-up time reported sufficient to be long enough for outcomes to occur? | Yes | Yes | Yes | N/A | N/A | Yes | N/A |
| 9. Was follow-up complete, and if not, were the reasons for loss to follow-up described and explored? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 10. Were strategies to address incomplete follow-up utilized? | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 11. Was appropriate statistical analysis used? | Unclear | Unclear | Yes | Yes | Yes | Yes | Unclear |
| 12. Quality evaluation | Include | Include | Include | Include | Include | Include | Include |